Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Colorectal Dis ; 25(8): 1646-1652, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-37464985

RESUMO

AIM: Intraoperative radiotherapy (IORT) decreases local recurrence rates for advanced rectal cancer. Nevertheless, utilization of IORT is limited due to the associated logistical and financial challenges. The aim of this study is to describe the development and delivery of a novel IORT protocol for advanced rectal cancer that overcomes these difficulties in the context of the early phase of an IDEAL 2a study. The primary outcome measure was the ability to deliver IORT using this novel protocol with IORT-related toxicity as the secondary outcome measure. METHOD: Consecutive patients with advanced rectal cancer expected to have involved (R1) resection margins were enrolled. After resection, 12 Gy low-energy photon IORT was delivered using the Axxent device with a custom-designed elliptical spherical balloon applicator. RESULTS: Six patients with a median age of 47 years (range 33-88 years; five women) were enrolled between 2018 and 2019. The indication was advanced cancer in four patients and atypical invasive pelvic side wall lymph nodes in two. IORT was successfully delivered in all cases. No toxicity was encountered. Three advanced cancer patients had R1 resection and one had complete resection (R0); resection margin status could not be established for the two lymph node cases. Five patients were alive at 3.4 (2.9-4.1) year follow-up. None of the R1 cases recurred. CONCLUSION: This is the first study to describe a novel IORT protocol using low-energy photon IORT for advanced rectal cancer. IORT could be delivered in all cases and no IORT-related toxicity was encountered. Available oncological outcome data are encouraging, but further studies will be necessary to determine the oncological effectiveness of this protocol.


Assuntos
Neoplasias Retais , Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Londres , Neoplasias Retais/radioterapia , Neoplasias Retais/cirurgia , Neoplasias Retais/patologia , Pelve/cirurgia , Cuidados Intraoperatórios , Recidiva Local de Neoplasia/cirurgia , Terapia Combinada , Ensaios Clínicos Fase II como Assunto
2.
N Z Med J ; 125(1363): 77-80, 2012 Oct 12.
Artigo em Inglês | MEDLINE | ID: mdl-23159904

RESUMO

We are presenting a case of non-traumatic spontaneous spinal subdural hematoma in a patient on warfarin and fluoxetine. This diagnosis should be considered early in patients who are on warfarin or fluoxetine or both presenting with acute neurological abnormalities of the limbs, and early decompression could result in good neurological outcome.


Assuntos
Fluoxetina/efeitos adversos , Hematoma Subdural Espinal , Laminectomia , Compressão da Medula Espinal , Varfarina/efeitos adversos , Idoso , Antifibrinolíticos/administração & dosagem , Dor nas Costas/fisiopatologia , Fatores de Coagulação Sanguínea/administração & dosagem , Terapia Combinada , Descompressão Cirúrgica/métodos , Dexametasona/administração & dosagem , Diagnóstico Precoce , Intervenção Médica Precoce/métodos , Fluoxetina/administração & dosagem , Glucocorticoides/administração & dosagem , Hematoma Subdural Espinal/induzido quimicamente , Hematoma Subdural Espinal/complicações , Hematoma Subdural Espinal/diagnóstico , Hematoma Subdural Espinal/fisiopatologia , Hematoma Subdural Espinal/cirurgia , Humanos , Imageamento por Ressonância Magnética/métodos , Masculino , Paraplegia/fisiopatologia , Compressão da Medula Espinal/diagnóstico , Compressão da Medula Espinal/etiologia , Compressão da Medula Espinal/fisiopatologia , Compressão da Medula Espinal/cirurgia , Resultado do Tratamento , Retenção Urinária/fisiopatologia , Vitamina K/administração & dosagem , Varfarina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...